metricas
covid
Buscar en
Acta Otorrinolaringológica Española
Toda la web
Inicio Acta Otorrinolaringológica Española Surgical Complications in Salvage Surgery of Patients With Head and Neck Carcino...
Journal Information
Vol. 58. Issue 10.
Pages 454-457 (January 2007)
Share
Share
Download PDF
More article options
Vol. 58. Issue 10.
Pages 454-457 (January 2007)
Original articles
Surgical Complications in Salvage Surgery of Patients With Head and Neck Carcinomas Treated With Concomitant Chemoradiotherapy (CCR)
Complicaciones quirúrgicas en la cirugía de rescate de pacientes con carcinomas de cabeza y cuello tratados con quimioterapia y radioterapia concomitantes
Visits
759
Alberto Encinas Vicente
Corresponding author
albertoencinas.orl@gmail.com

Correspondence: Laguna Negra, 1 C, 4.° B. 28030 Madrid. España.
, Rosalía Souvirón Encabo, Ángel Rodríguez Paramás, Marta Mancheño Losa, Fernando García de Pedro, Bartolomé Scola Yurrita
Servicio de Otorrinolaringología, Hospital General Universitario Gregorio Marañón, Madrid, Spain
This item has received
Article information
Introduction

One way of treating head and neck carcinomas is using concomitant chemoradiotherapy (CCR). In this study we will try to evaluate the incidence of complications in rescue surgery after CCR.

Material and method

We have studied data from 103 patients diagnosed as having stage III or IV squamous head and neck carcinoma between 1997 and 2005. They were treated following 2 different CCR protocols.

Results

Of the 103 patients, 26 (25%) required rescue surgery. Eight patients in this group (30.76% of those operated on) presented complications. The average stay in our department was 52.8 days (7-197 days).

Conclusions

Patients treated with CCR who have needed rescue surgery apparently have a higher rate of complications and a longer stay than those treated with surgery alone.

Key words:
Concomitant chemoradiotherapy
Rescue surgery
Complications
Pharyngostoma
Introducción

Una de las modalidades de tratamiento de los carcinomas epidermoides de cabeza y cuello es con radioterapia y quimioterapia concomitantes (RQC). En este estudio se intentará evaluar la incidencia de complicaciones que presenta la cirugía de rescate tras la realización de RQC.

Material y método

Se ha estudiado los datos de 103 pacientes diagnosticados de carcinoma epidermoide de cabeza y cuello en estadios III y IV tratados entre 1997 y 2005. Se los trató siguiendo dos protocolos distintos de RQC.

Resultados

De los 103 pacientes, requirieron cirugía de rescate 26 (25%). Dentro de este grupo presentaron complicaciones 8 pacientes (el 30,76% de los intervenidos). La estancia media en el servicio de otorrinolaringología fue de 52,8 (7-197) días.

Conclusiones

Los pacientes que han recibido RQC y han necesitado cirugía de rescate posteriormente presentan una aparente mayor tasa de complicaciones, así como un ingreso más prolongado, que aquellos en quienes inicialmente se opta por la cirugía.

Palabras clave:
Radioterapia y quimioterapia concomitantes
Cirugía de rescate
Complicaciones
Faringostoma

Article

These are the options to access the full texts of the publication Acta Otorrinolaringológica Española
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Acta Otorrinolaringológica Española

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos